US Broker Ratings

Viridian Therapeutics (VRDN) Investor Outlook: A Biotech Pioneer with 30.79% Potential Upside

Viridian Therapeutics, Inc. (NASDAQ: VRDN), a dynamic player in the biotechnology sector, has been capturing investor attention with its promising developments in the treatment of serious and rare diseases. Based..

Travere Therapeutics, Inc. (TVTX) Stock Analysis: Strong Revenue Growth and Bullish Analyst Ratings

Travere Therapeutics, Inc. (NASDAQ: TVTX), a biopharmaceutical leader in the healthcare sector, is catching the attention of investors with its robust revenue growth and favorable analyst ratings. Based in San..

Denali Therapeutics Inc. (DNLI) Investor Outlook: Unveiling a 94% Potential Upside in Biotechnology

Denali Therapeutics Inc. (NASDAQ: DNLI) is capturing the attention of investors within the biotechnology sector, thanks to a remarkable potential upside of 94.30% as indicated by analyst ratings. With a..

Celldex Therapeutics, Inc. (CLDX) Stock Analysis: A 104.98% Potential Upside with Strong Buy Ratings

Celldex Therapeutics, Inc. (NASDAQ: CLDX), a prominent player in the biotechnology sector, is making waves with its innovative therapeutic antibodies aimed at addressing severe inflammatory, allergic, autoimmune, and other diseases...

Ligand Pharmaceuticals (LGND) Stock Analysis: A Biotech Gem with 24.74% Potential Upside

Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) stands out in the biotechnology sector with its impressive growth metrics and a robust pipeline of biopharmaceutical assets. Based in Jupiter, Florida, Ligand specializes in..

ANI Pharmaceuticals, Inc. (ANIP) Investor Outlook: Exploring a Promising 34% Upside Potential

Investors eyeing the healthcare sector might want to give ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) a closer look. This biopharmaceutical company, headquartered in Baudette, Minnesota, is making waves in the drug..

Ultragenyx Pharmaceutical Inc. (RARE) Stock Report: Analyzing a Potential 259.79% Upside Amidst Innovative Biotech Developments

Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) stands as a compelling focus for investors interested in the biotechnology sector. With its current market cap at $1.9 billion and a strong emphasis on..

Adaptive Biotechnologies Corp (ADPT) Stock Analysis: A 19% Upside Awaits in the Biotech Sector

Adaptive Biotechnologies Corporation (NASDAQ: ADPT) stands out in the biotechnology sector with its innovative approach to diagnosing and treating diseases through its immune medicine platform. Headquartered in Seattle, Washington, this..

Dyne Therapeutics, Inc. (DYN) Stock Analysis: Exploring the 98% Potential Upside in Biotechnology

Dyne Therapeutics, Inc. (NASDAQ: DYN) has garnered significant attention in the biotechnology sector, thanks to its promising therapeutic pipeline and a striking potential upside of nearly 98.44%. As a clinical-stage..

Innoviva, Inc. (INVA) Stock Analysis: Unveiling a 64.81% Potential Upside

Innoviva, Inc. (NASDAQ: INVA) is capturing investor attention with a promising potential upside of 64.81%, as indicated by its average target price of $32.50. The biotechnology firm, headquartered in Burlingame,..

U.S. Physical Therapy, Inc. (USPH): Exploring the 29.37% Potential Upside and Analyst Optimism

Investors looking to capitalize on growth opportunities within the healthcare sector might want to consider U.S. Physical Therapy, Inc. (NYSE: USPH). With a market capitalization of $1.24 billion, this Houston-based..

MannKind Corporation (MNKD): Analyst Consensus Signals a 66.57% Upside Potential

MannKind Corporation (NASDAQ: MNKD), a prominent player in the healthcare sector specializing in biotechnology, is drawing considerable investor interest due to its promising growth trajectory and robust analyst ratings. The..

Teladoc Health, Inc. (TDOC) Stock Analysis: Assessing the 32% Potential Upside

Teladoc Health, Inc. (TDOC) stands as a pioneer in the burgeoning field of virtual healthcare services, offering a comprehensive suite of medical and mental health solutions under its Teladoc, Livongo,..

Structure Therapeutics Inc. (GPCR) Stock Analysis: 47.56% Potential Upside Sparks Investor Interest

Structure Therapeutics Inc. (NASDAQ: GPCR), a burgeoning name in the biotechnology sector, has captured investor attention with a compelling narrative centered around its promising pipeline of therapies targeting chronic diseases..

Warby Parker Inc. (WRBY) Stock Analysis: A Closer Look at the 14.49% Potential Upside

Warby Parker Inc. (NYSE: WRBY), a significant player in the eyewear industry, has captured investor attention with its innovative business model and rapid growth. As a company that has redefined..

CONMED Corporation (CNMD) Stock Analysis: Navigating a 16.68% Upside with Strategic Insights

As an established player in the healthcare sector, CONMED Corporation (NASDAQ: CNMD) is a medical technology company that has carved out a niche in the medical devices industry. Headquartered in..

Agios Pharmaceuticals, Inc. (AGIO) Investor Outlook: Analyzing a Potential 32.55% Upside

Agios Pharmaceuticals, Inc. (NASDAQ: AGIO), a trailblazer in the biotechnology sector, offers a compelling opportunity for investors drawn to the healthcare industry’s innovation. With a focus on cellular metabolism, Agios..

UFP Technologies, Inc. (UFPT) Stock Analysis: Exploring a 39.67% Upside Potential for Investors

UFP Technologies, Inc. (NASDAQ: UFPT), a prominent player in the medical devices industry, offers a unique blend of engineered custom solutions that caters to diverse sectors including healthcare, aerospace, defense,..

Apogee Therapeutics, Inc. (APGE): Investor Outlook on Its 26.80% Potential Upside

Apogee Therapeutics, Inc. (NASDAQ: APGE), a burgeoning player in the biotechnology sector, has caught the attention of investors with its robust pipeline and a promising average target price that suggests..

GoodRx Holdings, Inc. (GDRX) Stock Analysis: Exploring an 81% Potential Upside

GoodRx Holdings, Inc. (NASDAQ: GDRX) stands as a compelling player within the healthcare sector, particularly in the Health Information Services industry. Headquartered in Santa Monica, California, this company has carved..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds